Collection
MeSH Terms
breast cancer, neoplasm, carcinoma, malignancy, tumor, oncotype, prosigna, PAM50, mammaprint, 70 gene, endopredict, breast cancer index, BCI, tailorx, rxponder, swog, swog S1007, swog S8814, nsabp, nsabp b20, nsabp b-20, nsabp b 20, nsabp b14, nsabp b-14, nsabp b 14, transatac, ma17, ma 17, ma-17, ma12, ma 12, ma-12, ABCSG-6, ABCSG 6, ABCSG-8, ABCSG 8, mindact, raster adj2 study, geicam 9906, geicam-9906, geicam9906, OPTIMA adj2 study, 21 gene, recurrence score
Keywords
breast cancer, oncotype dx, prosigna, mammaprint, endopredict, breast cancer index
Date for Review
In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Record Publish Year
2022
Publication Date
2022-01-28
Date of Last Evidence Search
2021-12-15
Methods Applied
Systematic review-based,
Externally reviewed,
Evidence quality assessment,
Patient/survivors/caregivers participation
Externally reviewed,
Evidence quality assessment,
Patient/survivors/caregivers participation
Guideline Contact
Duvaraga Sivajohanathan; pebconc@mcmaster.ca
Publication Scope
Guidelines
prognosis
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
PEBC (Program in evidenced-based care)
Publication Year
2022